Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Shijiazhuang Dingmin pharmaceutical Sciences Co.,Ltd
sales@dingminpharma.com
86-311-67260775
Modèle: 1038915-60-4
marque: DM
Appearance: Powder
Détails d'emballage: Double PE avec sac en aluminium
productivité: 100kg/month
transport: Ocean,Air
Lieu d'origine: Hebei, Chine
Soutenir: 100kg/month
Certificats : ISO9001
Hafen: Shanghai
Type de paiement: L/C,T/T
Incoterm: FOB,CIF
Le niraparib est un inhibiteur de PARP à petite molécule par voie orale développé par Tesaro pour traiter le cancer de l'ovaire.
Le niraparib est utilisé pour le traitement d'entretien des patients adultes atteints d'ovaire épithélial récurrent, de tube de Fallope ou de cancer péritonéal primaire qui sont en réponse complète ou partielle à la chimiothérapie à base de platine.
Test Items |
Specification |
Test Results |
Appearance |
White powder |
White powder |
Melting point |
125~127°C |
Conforms |
Specific Rotation |
+28°~+30° |
+29° |
Acidity(PH) |
5.2~6.5 |
5.8~6.2 |
Water |
4.0%~5.5% |
5.0% |
Residue On Ignition |
Not more than 0.1% |
Conforms |
N.N - dimethylaniline |
Comply with the standard |
Conforms |
Phenolic Compounds |
Comply with the standard |
Conforms |
Related Substance |
Comply with the standard |
Conforms |
Assay |
Between99.0~102.0% |
99.53% |
Conclusion |
This batch is complies with USP 41 |
Groupes de Produits : API et intermédiaires > Poudre API
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Fill in more information so that we can get in touch with you faster
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.